Evidence map›Paper›PMID 27136321›Full record

ArticleACS applied materials & interfaces2016

In Vitro Multitissue Interface Model Supports Rapid Vasculogenesis and Mechanistic Study of Vascularization across Tissue Compartments.

Kevin P Buno, Xuemei Chen, Justin A Weibel, Stephanie N Thiede, Suresh V Garimella, Mervin C Yoder, Sherry L Voytik-Harbin

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kevin P BunoWeldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Xuemei ChenSchool of Mechanical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Justin A WeibelSchool of Mechanical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Stephanie N ThiedeWeldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Suresh V GarimellaSchool of Mechanical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Mervin C YoderWeldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Sherry L Voytik-HarbinWeldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
Purdue University West Lafayette · USIndiana University School of Medicine

Funding

Collagen Cross-links Direct Matrix-Induced Vasculogenesis Via Tunable PathwaysR01HL109602 · NHLBI · PURDUE UNIVERSITY · PI VOYTIK-HARBIN, SHERRY L, YODER, MERVIN C. · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL109602
6 · The paper itself

Abstract

A significant challenge facing tissue engineers is the design and development of complex multitissue systems, including vascularized tissue-tissue interfaces. While conventional in vitro models focus on either vasculogenesis (de novo formation of blood vessels) or angiogenesis (vessels sprouting from existing vessels or endothelial monolayers), successful therapeutic vascularization strategies will likely rely on coordinated integration of both processes. To address this challenge, we developed a novel in vitro multitissue interface model in which human endothelial colony forming cell (ECFC)-encapsulated tissue spheres are embedded within a surrounding tissue microenvironment. This highly reproducible approach exploits biphilic surfaces (nanostructured surfaces with distinct superhydrophobic and hydrophilic regions) to (i) support tissue compartments with user-specified matrix composition and physical properties as well as cell type and density and (ii) introduce boundary conditions that prevent the cell-mediated tissue contraction routinely observed with conventional three-dimensional monodispersion cultures. This multitissue interface model was applied to test the hypothesis that independent control of cell-extracellular matrix (ECM) and cell-cell interactions would affect vascularization within the tissue sphere as well as across the tissue-tissue interface. We found that high-cell-density tissue spheres containing 5 × 10(6) ECFCs/mL exhibit rapid and robust vasculogenesis, forming highly interconnected, stable (as indicated by type IV collagen deposition) vessel networks within only 3 days. Addition of adipose-derived stromal cells (ASCs) in the surrounding tissue further enhanced vasculogenesis within the sphere as well as angiogenic vessel elongation across the tissue-tissue boundary, with both effects being dependent on the ASC density. Overall, results show that the ECFC density and ECFC-ASC crosstalk, in terms of paracrine and mechanophysical signaling, are critical determinants of vascularization within a given tissue compartment and across tissue interfaces. This new in vitro multitissue interface model and the associated mechanistic insights it yields provide guiding principles for the design and optimization of multitissue vascularization strategies for research and clinical applications.

Indexed as

Neovascularization, PhysiologicCell DifferentiationEndothelial CellsHumansNeovascularization, PathologicTissue Engineeringadipose-derived stromal cells (ASCs)collagen oligomersendothelial colony forming cells (ECFCs)mechanobiologymultitissue interfacetissue engineeringvascularization

Identifiers

PMID27136321
PMCPMC5007191
OpenAlexW2346679866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.